10x Genomics (TXG) Net Income towards Common Stockholders Growth (1y) (2019 - 2026)

10x Genomics (TXG) Net Income towards Common Stockholders Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 14.35%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 275.50%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 28.75%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -71.96%
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 60.80%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn -69.40%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 48.00%
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -38.64%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 262.39%
10 Teladoc Health 1.45 Bn 696.57 Mn 562.57 Mn 31.33%

Historic Data

Download Data
DateValue
Mar 31, 2026 60.80%
Dec 31, 2025 66.85%
Sep 30, 2025 23.16%
Jun 30, 2025 191.14%
Mar 31, 2025 42.69%
Dec 31, 2024 -0.16%
Sep 30, 2024 61.55%
Jun 30, 2024 39.28%
Mar 31, 2024 -18.13%
Dec 31, 2023 -184.36%
Sep 30, 2023 -121.85%
Jun 30, 2023 3.17%
Mar 31, 2023 -19.65%
Dec 31, 2022 6.69%
Sep 30, 2022 -144.10%
Jun 30, 2022 -483.22%
Mar 31, 2022 -267.18%
Dec 31, 2021 95.56%
Sep 30, 2021 73.92%
Jun 30, 2021 72.48%